Gene Therapy, lentiviral vector production, quality and yield, major-splice-donor aberrant splicing, vector RNA genome integrity and packaging, 2KO-LV genome, Transgene Repression in vector Production (TRiP) System[TM], U1 snRNA-based lentiviral vector enhancer, CAR-T cell therapy, TetraVecta[TM] System